Clinical Trial Update: Study of Apalutamide With Carotuximab in Metastatic, Castration-Resistant Prostate Cancer [Phase 2]

View source ↗

Summary

This clinical trial update describes a Phase 2 study evaluating the combination of apalutamide with carotuximab for metastatic castration-resistant prostate can…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Castration-resistant Prostate Cancer

Drugs mentioned

• Carotuximab (carotuximab)
• ERLEADA (apalutamide)

Snippet

Sponsor: Edwin Posadas, MD | Conditions: Castration-resistant Prostate Cancer | Phase 2 | Status: RECRUITING